Alexandra Martin
Pediatric Endocrinology · Chattanooga, TNNPI 1730340787
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.3% of the total across 138 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 19.2% — the pattern of someone who eats at a lot of different presentations.
Across 138 payments — averaging $22.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$591
- Abbott$213
- Ultragenyx Pharmaceutical Inc.$202
- Sanofi-aventis U.S. LLC$195
- Insulet Corporation$191
- Medtronic$181
- plus $1K from 28 others
Across 1 payment — averaging $94,372 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$94K
What the payments were for
- Food & beverage$3,04999%
- Education$221%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 38 | $591 |
| Abbott | 11 | $213 |
| Ultragenyx Pharmaceutical Inc. | 2 | $202 |
| Sanofi-aventis U.S. LLC | 6 | $195 |
| Insulet Corporation | 8 | $191 |
| Medtronic | 4 | $181 |
| Pfizer | 7 | $131 |
| Eton Pharmaceuticals, Inc. | 3 | $129 |
| Azurity Pharmaceuticals, Inc. | 6 | $124 |
| Ascendis Pharma Endocrinology Inc | 6 | $122 |
| Xeris Pharmaceuticals, Inc. | 6 | $114 |
| Biomarin Pharmaceutical Inc. | 4 | $70 |
| Regeneron Healthcare Solutions, Inc. | 3 | $69 |
| Tandem Diabetes Care, Inc. | 3 | $57 |
| Endo Pharmaceuticals Inc. | 3 | $57 |
| AstraZeneca(2 entities) | 3 | $55 |
| Mannkind Corporation | 2 | $49 |
| Boston Scientific | 1 | $48 |
| Zealand Pharma US, Inc. | 2 | $44 |
| Endo USA, Inc. | 2 | $43 |
| Arbor Pharmaceuticals, Inc. | 2 | $43 |
| Ferring Pharmaceuticals Inc. | 2 | $37 |
| Dexcom, Inc. | 1 | $33 |
| Rhythm Pharmaceuticals, Inc. | 2 | $31 |
| Neurocrine Biosciences, Inc. | 1 | $31 |
| ANI Pharmaceuticals, Inc. | 1 | $30 |
| Leadiant Biosciences, Inc. | 1 | $30 |
| Lilly USA, LLC | 2 | $29 |
| BETA Bionics, Inc. | 1 | $24 |
| Novo Nordisk | 1 | $23 |
| Amneal Pharmaceuticals LLC | 1 | $23 |
| Tolmar Pharmaceuticals, Inc. | 1 | $19 |
| IBSA Pharma Inc. | 1 | $18 |
| Soleno Therapeutics, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Alkindi$100
How this compares
$3,071 in reported general payments places this provider in the 60th percentile of 37 pediatric endocrinology providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 12 | $46 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $23 | $4612 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 37 pediatric endocrinology providers in Tennessee.
Other pediatric endocrinology in Chattanooga
- Rita ShridharaniChattanooga$4K
- Justin GregoryNashville$254K
- Nidhi GuptaFranklin$157K
- Ashley ShoemakerNashville$50K
- Jill SimmonsNashville$43K
- Daniel MooreNashville$32K
- George FordJohnson City$14K
- Leah AkinseyeMemphis$14K
- Ana KarabellMemphis$14K
- Evan LosJohnson City$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.